{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:18:42Z","timestamp":1787757522480,"version":"build-2784847793"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012036","name":"Lotte Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012036","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Koyanaki Foundation"},{"name":"Vichy Laboratoires"},{"DOI":"10.13039\/100030844","name":"Lydia O\u2019Leary Memorial Pias Dermatological Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030844","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["25K19543"],"award-info":[{"award-number":["25K19543"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["24K11459"],"award-info":[{"award-number":["24K11459"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-026-09196-w","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:23:30Z","timestamp":1787754210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rewiring Atopic Dermatitis: Alarmin Cytokines at the Core of Barrier\u2013Immune\u2013Neuro\u2013Microbiome Networks"],"prefix":"10.1007","volume":"69","author":[{"given":"Nafisah Oyinkansola","family":"Akim-Shittu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alafate","family":"Abudouwanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideoki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Niyonsaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"10478","key":"9196_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","volume":"405","author":"E Guttman-Yassky","year":"2025","unstructured":"Guttman-Yassky E, Renert-Yuval Y, Brunner PM (2025) Atopic dermatitis. Lancet 405(10478):583\u2013596. https:\/\/doi.org\/10.1016\/S0140-6736(24)02519-4","journal-title":"Lancet"},{"key":"9196_CR2","doi-asserted-by":"publisher","first-page":"1567817","DOI":"10.3389\/fimmu.2025.1567817","volume":"16","author":"YF Luo","year":"2025","unstructured":"Luo YF, Deng Y, Yang F, Meiduosiji, Xiong X, Yuan YL et al (2025) The role of ILC2s in asthma combined with atopic dermatitis: bridging the gap from research to clinical practice. Front Immunol 16:1567817. https:\/\/doi.org\/10.3389\/fimmu.2025.1567817","journal-title":"Front Immunol"},{"issue":"9","key":"9196_CR3","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/eji.201948156","volume":"49","author":"L Cosmi","year":"2019","unstructured":"Cosmi L, Maggi L, Mazzoni A, Liotta F, Annunziato F (2019) Biologicals targeting type 2 immunity: lessons learned from asthma, chronic urticaria and atopic dermatitis. Eur J Immunol 49(9):1334\u20131343. https:\/\/doi.org\/10.1002\/eji.201948156","journal-title":"Eur J Immunol"},{"issue":"6","key":"9196_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41588-018-0121-0","volume":"50","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Lee PH, Chaffin MD, Chung W, Loh P-R, Lu Q et al (2018) A genome-wide cross-trait analysis from UK Biobank highlights the shared genetic architecture of asthma and allergic diseases. Nat Genet 50(6):857\u2013864. https:\/\/doi.org\/10.1038\/s41588-018-0121-0","journal-title":"Nat Genet"},{"issue":"3","key":"9196_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jdermsci.2021.04.007","volume":"102","author":"T Luger","year":"2021","unstructured":"Luger T, Amagai M, Dreno B, Dagnelie MA, Liao W, Kabashima K et al (2021) Atopic dermatitis: role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci 102(3):142\u2013157. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.04.007","journal-title":"J Dermatol Sci"},{"issue":"1","key":"9196_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.alit.2021.11.001","volume":"71","author":"LF Koh","year":"2022","unstructured":"Koh LF, Ong RY, Common JE (2022) Skin microbiome of atopic dermatitis. Allergol Int 71(1):31\u201339. https:\/\/doi.org\/10.1016\/j.alit.2021.11.001","journal-title":"Allergol Int"},{"issue":"24","key":"9196_CR7","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3390\/cells12242793","volume":"12","author":"PR Upadhyay","year":"2023","unstructured":"Upadhyay PR, Seminario-Vidal L, Abe B, Ghobadi C, Sims JT (2023) Cytokines and epidermal lipid abnormalities in atopic dermatitis: a systematic review. Cells 12(24):2793. https:\/\/doi.org\/10.3390\/cells12242793","journal-title":"Cells"},{"key":"9196_CR8","doi-asserted-by":"publisher","first-page":"876515","DOI":"10.3389\/fimmu.2022.876515","volume":"13","author":"T Hasegawa","year":"2022","unstructured":"Hasegawa T, Oka T, Demehri S (2022) Alarmin cytokines as central regulators of cutaneous immunity. Front Immunol 13:876515. https:\/\/doi.org\/10.3389\/fimmu.2022.876515","journal-title":"Front Immunol"},{"key":"9196_CR9","doi-asserted-by":"publisher","first-page":"801579","DOI":"10.3389\/fimmu.2022.801579","volume":"13","author":"M Humeau","year":"2022","unstructured":"Humeau M, Boniface K, Bodet C (2022) Cytokine-mediated crosstalk between keratinocytes and T cells in atopic dermatitis. Front Immunol 13:801579. https:\/\/doi.org\/10.3389\/fimmu.2022.801579","journal-title":"Front Immunol"},{"issue":"1","key":"9196_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/imr.12706","volume":"286","author":"H Kabata","year":"2018","unstructured":"Kabata H, Moro K, Koyasu S (2018) The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. Immunol Rev 286(1):37\u201352. https:\/\/doi.org\/10.1111\/imr.12706","journal-title":"Immunol Rev"},{"issue":"3","key":"9196_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4172\/2155-9899.1000110","volume":"2","author":"EB Brandt","year":"2011","unstructured":"Brandt EB, Sivaprasad U (2011) Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2(3):110. https:\/\/doi.org\/10.4172\/2155-9899.1000110","journal-title":"J Clin Cell Immunol"},{"issue":"3","key":"9196_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5213\/inj.2015.19.3.142","volume":"19","author":"TY Jang","year":"2015","unstructured":"Jang TY, Kim YH (2015) Interleukin-33 and mast cells bridge innate and adaptive immunity: from the allergologist\u2019s perspective. Int Neurourol J 19(3):142\u2013150. https:\/\/doi.org\/10.5213\/inj.2015.19.3.142","journal-title":"Int Neurourol J"},{"issue":"7","key":"9196_CR13","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.4049\/jimmunol.1401307","volume":"193","author":"BS Kim","year":"2014","unstructured":"Kim BS, Wang K, Siracusa MC, Saenz SA, Brestoff JR, Monticelli LA et al (2014) Basophils promote innate lymphoid cell responses in inflamed skin. J Immunol 193(7):3717\u20133725. https:\/\/doi.org\/10.4049\/jimmunol.1401307","journal-title":"J Immunol"},{"issue":"7","key":"9196_CR14","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/all.14318","volume":"75","author":"CA Akdis","year":"2020","unstructured":"Akdis CA, Arkwright PD, Br\u00fcggen MC, Busse W, Gadina M, Guttman-Yassky E et al (2020) Type 2 immunity in the skin and lungs. Allergy 75(7):1582\u20131605. https:\/\/doi.org\/10.1111\/all.14318","journal-title":"Allergy"},{"key":"9196_CR15","doi-asserted-by":"publisher","first-page":"1342176","DOI":"10.3389\/fmed.2024.1342176","volume":"11","author":"Y Yamamura","year":"2024","unstructured":"Yamamura Y, Nakashima C, Otsuka A (2024) Interplay of cytokines in the pathophysiology of atopic dermatitis: insights from Murin models and human. Front Med (Lausanne) 11:1342176. https:\/\/doi.org\/10.3389\/fmed.2024.1342176","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"9196_CR16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/all.16108","volume":"79","author":"E Guttman-Yassky","year":"2024","unstructured":"Guttman-Yassky E, Kabashima K, Staumont-Salle D, Nahm WK, Pauser S, Da Rosa JC et al (2024) Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years. Allergy 79(6):1560\u20131572. https:\/\/doi.org\/10.1111\/all.16108","journal-title":"Allergy"},{"issue":"5","key":"9196_CR17","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jaip.2023.02.005","volume":"11","author":"EH van den Bogaard","year":"2023","unstructured":"van den Bogaard EH, Elias PM, Goleva E, Berdyshev E, Smits JPH, Danby SG et al (2023) Targeting skin barrier function in atopic dermatitis. J Allergy Clin Immunol Pract 11(5):1335\u20131346. https:\/\/doi.org\/10.1016\/j.jaip.2023.02.005","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"9196_CR18","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.4110\/in.2022.22.e11","volume":"22","author":"J Ham","year":"2022","unstructured":"Ham J, Shin JW, Ko BC, Kim HY (2022) Targeting the epithelium-derived innate cytokines: from bench to bedside. Immune Netw 22(1):e11. https:\/\/doi.org\/10.4110\/in.2022.22.e11","journal-title":"Immune Netw"},{"issue":"2","key":"9196_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","volume":"155","author":"SR Wilson","year":"2013","unstructured":"Wilson SR, Th\u00e9 L, Batia LM, Beattie K, Katibah GE, McClain SP et al (2013) The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155(2):285\u2013295. https:\/\/doi.org\/10.1016\/j.cell.2013.08.057","journal-title":"Cell"},{"issue":"4","key":"9196_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.jaci.2021.09.014","volume":"149","author":"AM Trier","year":"2022","unstructured":"Trier AM, Mack MR, Fredman A, Tamari M, Ver Heul AM, Zhao Y et al (2022) IL-33 signaling in sensory neurons promotes dry skin itch. J Allergy Clin Immunol 149(4):1473\u201380e6. https:\/\/doi.org\/10.1016\/j.jaci.2021.09.014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9196_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/pathogens11040422","volume":"11","author":"EJ Chung","year":"2022","unstructured":"Chung EJ, Luo C-H, Thio CL-P, Chang Y-J (2022) Immunomodulatory role of staphylococcus aureus in atopic dermatitis. Pathogens 11(4):422. https:\/\/doi.org\/10.3390\/pathogens11040422","journal-title":"Pathogens"},{"key":"9196_CR22","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3389\/fimmu.2020.01740","volume":"11","author":"T Buhl","year":"2020","unstructured":"Buhl T, Ikoma A, Kempkes C, Cevikbas F, Sulk M, Buddenkotte J et al (2020) Protease-activated receptor-2 regulates neuro-epidermal communication in atopic dermatitis. Front Immunol 11:1740. https:\/\/doi.org\/10.3389\/fimmu.2020.01740","journal-title":"Front Immunol"},{"issue":"5","key":"9196_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373\u2013384. https:\/\/doi.org\/10.1038\/ni.1863","journal-title":"Nat Immunol"},{"issue":"3","key":"9196_CR24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.immuni.2019.02.023","volume":"50","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi T, Naik S, Nagao K (2019) Choreographing immunity in the skin epithelial barrier. Immunity 50(3):552\u2013565. https:\/\/doi.org\/10.1016\/j.immuni.2019.02.023","journal-title":"Immunity"},{"issue":"1","key":"9196_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","volume":"23","author":"R Ebina-Shibuya","year":"2023","unstructured":"Ebina-Shibuya R, Leonard WJ (2023) Role of thymic stromal lymphopoietin in allergy and beyond. Nat Rev Immunol 23(1):24\u201337. https:\/\/doi.org\/10.1038\/s41577-022-00735-y","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"9196_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2332\/allergolint.11-RAI-0395","volume":"61","author":"T Takai","year":"2012","unstructured":"Takai T (2012) TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol Int 61(1):3\u201317. https:\/\/doi.org\/10.2332\/allergolint.11-RAI-0395","journal-title":"Allergol Int"},{"key":"9196_CR27","doi-asserted-by":"publisher","first-page":"1700060","DOI":"10.3389\/falgy.2025.1700060","volume":"6","author":"HK Komori","year":"2025","unstructured":"Komori HK, Ortega H (2025) Potential of alarmin-targeted bispecific and combination therapies in airway disease. Front Allergy 6:1700060. https:\/\/doi.org\/10.3389\/falgy.2025.1700060","journal-title":"Front Allergy"},{"issue":"7","key":"9196_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ni805","volume":"3","author":"V Soumelis","year":"2002","unstructured":"Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3(7):673\u2013680. https:\/\/doi.org\/10.1038\/ni805","journal-title":"Nat Immunol"},{"issue":"3","key":"9196_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cei.12021","volume":"171","author":"Y Sano","year":"2013","unstructured":"Sano Y, Masuda K, Tamagawa-Mineoka R, Matsunaka H, Murakami Y, Yamashita R et al (2013) Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis. Clin Exp Immunol 171(3):330\u2013337. https:\/\/doi.org\/10.1111\/cei.12021","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"9196_CR30","doi-asserted-by":"publisher","first-page":"21895","DOI":"10.1038\/s41598-020-78943-6","volume":"10","author":"M-L Clausen","year":"2020","unstructured":"Clausen M-L, Kezic S, Olesen CM, Agner T (2020) Cytokine concentration across the stratum corneum in atopic dermatitis and healthy controls. Sci Rep 10(1):21895. https:\/\/doi.org\/10.1038\/s41598-020-78943-6","journal-title":"Sci Rep"},{"issue":"4","key":"9196_CR31","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1172\/jci124606","volume":"129","author":"F Roan","year":"2019","unstructured":"Roan F, Obata-Ninomiya K, Ziegler SF (2019) Epithelial cell-derived cytokines: more than just signaling the alarm. J Clin Invest 129(4):1441\u20131451. https:\/\/doi.org\/10.1172\/jci124606","journal-title":"J Clin Invest"},{"issue":"9","key":"9196_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.20051135","volume":"202","author":"T Ito","year":"2005","unstructured":"Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N et al (2005) TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202(9):1213\u20131223. https:\/\/doi.org\/10.1084\/jem.20051135","journal-title":"J Exp Med"},{"issue":"1","key":"9196_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/intimm\/dxv050","volume":"28","author":"TY Halim","year":"2016","unstructured":"Halim TY (2016) Group 2 innate lymphoid cells in disease. Int Immunol 28(1):13\u201322. https:\/\/doi.org\/10.1093\/intimm\/dxv050","journal-title":"Int Immunol"},{"issue":"11","key":"9196_CR34","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1586\/1744666x.2014.967684","volume":"10","author":"A Cianferoni","year":"2014","unstructured":"Cianferoni A, Spergel J (2014) The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Rev Clin Immunol 10(11):1463\u20131474. https:\/\/doi.org\/10.1586\/1744666x.2014.967684","journal-title":"Expert Rev Clin Immunol"},{"issue":"45","key":"9196_CR35","doi-asserted-by":"publisher","first-page":"19455","DOI":"10.1073\/pnas.1008271107","volume":"107","author":"Y Rochman","year":"2010","unstructured":"Rochman Y, Kashyap M, Robinson GW, Sakamoto K, Gomez-Rodriguez J, Wagner KU et al (2010) Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Proc Natl Acad Sci U S A 107(45):19455\u201319460. https:\/\/doi.org\/10.1073\/pnas.1008271107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2014","key":"9196_CR36","doi-asserted-by":"publisher","first-page":"bau007","DOI":"10.1093\/database\/bau007","volume":"2014","author":"J Zhong","year":"2014","unstructured":"Zhong J, Sharma J, Raju R, Palapetta SM, Prasad TSK, Huang T-C et al (2014) TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. Database 2014(2014):bau007. https:\/\/doi.org\/10.1093\/database\/bau007","journal-title":"Database"},{"issue":"105","key":"9196_CR37","doi-asserted-by":"publisher","first-page":"ra4","DOI":"10.1126\/scisignal.2000567","volume":"3","author":"K Arima","year":"2010","unstructured":"Arima K, Watanabe N, Hanabuchi S, Chang M, Sun S-C, Liu Y-J (2010) Distinct signal codes generate dendritic cell functional plasticity. Sci Signal 3(105):ra4. https:\/\/doi.org\/10.1126\/scisignal.2000567","journal-title":"Sci Signal"},{"issue":"10","key":"9196_CR38","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1084\/jem.20090153","volume":"206","author":"N Lu","year":"2009","unstructured":"Lu N, Wang Y-H, Wang Y-H, Arima K, Hanabuchi S, Liu Y-J (2009) TSLP and IL-7 use two different mechanisms to regulate human CD4\u2009+\u2009T cell homeostasis. J Exp Med 206(10):2111\u20132119. https:\/\/doi.org\/10.1084\/jem.20090153","journal-title":"J Exp Med"},{"issue":"4","key":"9196_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ni.2541","volume":"14","author":"BD Bell","year":"2013","unstructured":"Bell BD, Kitajima M, Larson RP, Stoklasek TA, Dang K, Sakamoto K et al (2013) The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses. Nat Immunol 14(4):364\u2013371. https:\/\/doi.org\/10.1038\/ni.2541","journal-title":"Nat Immunol"},{"issue":"3","key":"9196_CR40","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1165\/rcmb.2008-0041OC","volume":"40","author":"M Harada","year":"2009","unstructured":"Harada M, Hirota T, Jodo AI, Doi S, Kameda M, Fujita K et al (2009) Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells. Am J Respir Cell Mol Biol 40(3):368\u2013374. https:\/\/doi.org\/10.1165\/rcmb.2008-0041OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"9196_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jaci.2015.04.011","volume":"136","author":"G Fornasa","year":"2015","unstructured":"Fornasa G, Tsilingiri K, Caprioli F, Botti F, Mapelli M, Meller S et al (2015) Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin. J Allergy Clin Immunol 136(2):413\u2013422. https:\/\/doi.org\/10.1016\/j.jaci.2015.04.011","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"9196_CR42","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.3390\/ijms262010162","volume":"26","author":"J \u0141acwik","year":"2025","unstructured":"\u0141acwik J, Kraik K, Laska J, Tota M, S\u0119dek \u0141, Gomu\u0142ka K (2025) IL-31\/33 axis in atopic dermatitis. Int J Mol Sci 26(20):10162. https:\/\/doi.org\/10.3390\/ijms262010162","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9196_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.smim.2013.10.006","volume":"25","author":"MU Martin","year":"2013","unstructured":"Martin MU (2013) Special aspects of interleukin-33 and the IL-33 receptor complex. Semin Immunol 25(6):449\u2013457. https:\/\/doi.org\/10.1016\/j.smim.2013.10.006","journal-title":"Semin Immunol"},{"issue":"4","key":"9196_CR44","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.cellin.2022.100042","volume":"1","author":"X-M Yi","year":"2022","unstructured":"Yi X-M, Lian H, Li S (2022) Signaling and functions of interleukin-33 in immune regulation and diseases. Cell Insight 1(4):100042. https:\/\/doi.org\/10.1016\/j.cellin.2022.100042","journal-title":"Cell Insight"},{"issue":"22","key":"9196_CR45","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1002\/1873-3468.70113","volume":"599","author":"C Zeyneloglu","year":"2025","unstructured":"Zeyneloglu C, Babayev H, Ogulur I, Ardicli S, Pat Y, Yazici D et al (2025) The epithelial barrier theory proposes a comprehensive explanation for the origins of allergic and other chronic noncommunicable diseases. FEBS Lett 599(22):3208\u20133243. https:\/\/doi.org\/10.1002\/1873-3468.70113","journal-title":"FEBS Lett"},{"issue":"7","key":"9196_CR46","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.4049\/jimmunol.1003020","volume":"186","author":"H Kouzaki","year":"2011","unstructured":"Kouzaki H, Iijima K, Kobayashi T, O\u2019Grady SM, Kita H (2011) The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 186(7):4375\u20134387. https:\/\/doi.org\/10.4049\/jimmunol.1003020","journal-title":"J Immunol"},{"issue":"1","key":"9196_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","volume":"31","author":"AU L\u00fcthi","year":"2009","unstructured":"L\u00fcthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C et al (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31(1):84\u201398. https:\/\/doi.org\/10.1016\/j.immuni.2009.05.007","journal-title":"Immunity"},{"issue":"22","key":"9196_CR48","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1073\/pnas.0812690106","volume":"106","author":"C Cayrol","year":"2009","unstructured":"Cayrol C, Girard J-P (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 106(22):9021\u20139026. https:\/\/doi.org\/10.1073\/pnas.0812690106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"9196_CR49","doi-asserted-by":"publisher","first-page":"15502","DOI":"10.1073\/pnas.1410700111","volume":"111","author":"E Lefran\u00e7ais","year":"2014","unstructured":"Lefran\u00e7ais E, Duval A, Mirey E, Roga S, Espinosa E, Cayrol C et al (2014) Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci U S A 111(43):15502\u201315507. https:\/\/doi.org\/10.1073\/pnas.1410700111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"9196_CR50","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/all.15678","volume":"78","author":"WT Soh","year":"2023","unstructured":"Soh WT, Zhang J, Hollenberg MD, Vliagoftis H, Rothenberg ME, Sokol CL et al (2023) Protease allergens as initiators-regulators of allergic inflammation. Allergy 78(5):1148\u20131168. https:\/\/doi.org\/10.1111\/all.15678","journal-title":"Allergy"},{"key":"9196_CR51","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.1038\/ncomms9327","volume":"6","author":"ES Cohen","year":"2015","unstructured":"Cohen ES, Scott IC, Majithiya JB, Rapley L, Kemp BP, England E et al (2015) Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat Commun 6:8327. https:\/\/doi.org\/10.1038\/ncomms9327","journal-title":"Nat Commun"},{"issue":"4","key":"9196_CR52","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00414-023-03025-x","volume":"137","author":"Y Gao","year":"2023","unstructured":"Gao Y, Cai L, Li D, Li L, Wu Y, Ren W et al (2023) Extended characterization of IL-33\/ST2 as a predictor for wound age determination in skin wound tissue samples of humans and mice. Int J Legal Med 137(4):1287\u20131299. https:\/\/doi.org\/10.1007\/s00414-023-03025-x","journal-title":"Int J Legal Med"},{"issue":"5","key":"9196_CR53","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/jid.2011.446","volume":"132","author":"T Savinko","year":"2012","unstructured":"Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtim\u00e4ki S et al (2012) IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 132(5):1392\u20131400. https:\/\/doi.org\/10.1038\/jid.2011.446","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9196_CR54","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/all.13294","volume":"73","author":"M Ro","year":"2018","unstructured":"Ro M, Lee AJ, Kim JH (2018) 5-\/12-Lipoxygenase-linked cascade contributes to the IL-33-induced synthesis of IL-13 in mast cells, thus promoting asthma development. Allergy 73(2):350\u2013360. https:\/\/doi.org\/10.1111\/all.13294","journal-title":"Allergy"},{"issue":"1","key":"9196_CR55","doi-asserted-by":"publisher","first-page":"103953","DOI":"10.1016\/j.autrev.2025.103953","volume":"25","author":"F Verhoeven","year":"2025","unstructured":"Verhoeven F, Hannani D, Demougeot C, Meyer F, Wendling D, Prati C et al (2025) IL-33 in spondyloarthritis, the missing key. Autoimmun Rev 25(1):103953. https:\/\/doi.org\/10.1016\/j.autrev.2025.103953","journal-title":"Autoimmun Rev"},{"issue":"10","key":"9196_CR56","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrd2660","volume":"7","author":"R Kakkar","year":"2008","unstructured":"Kakkar R, Lee RT (2008) The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7(10):827\u2013840. https:\/\/doi.org\/10.1038\/nrd2660","journal-title":"Nat Rev Drug Discov"},{"key":"9196_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","volume":"8","author":"B Griesenauer","year":"2017","unstructured":"Griesenauer B, Paczesny S (2017) The ST2\/IL-33 axis in immune cells during inflammatory diseases. Front Immunol 8:475. https:\/\/doi.org\/10.3389\/fimmu.2017.00475","journal-title":"Front Immunol"},{"key":"9196_CR58","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3389\/fimmu.2018.02004","volume":"9","author":"H Takatori","year":"2018","unstructured":"Takatori H, Makita S, Ito T, Matsuki A, Nakajima H (2018) Regulatory mechanisms of IL-33-ST2-mediated allergic inflammation. Front Immunol 9:2004. https:\/\/doi.org\/10.3389\/fimmu.2018.02004","journal-title":"Front Immunol"},{"issue":"6","key":"9196_CR59","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1002\/ehf2.14111","volume":"9","author":"E Mehrabi Nasab","year":"2022","unstructured":"Mehrabi Nasab E, Hassanzadeh Makoei R, Aghajani H, Athari SS (2022) IL-33\/ST2 pathway as upper-hand of inflammation in allergic asthma contributes as predictive biomarker in heart failure. ESC Heart Fail 9(6):3785\u20133790. https:\/\/doi.org\/10.1002\/ehf2.14111","journal-title":"ESC Heart Fail"},{"issue":"9","key":"9196_CR60","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1089\/jir.2015.0159","volume":"36","author":"H-Y Du","year":"2016","unstructured":"Du H-Y, Fu H-Y, Li D-N, Qiao Y, Wang Q-W, Liu W (2016) The expression and regulation of interleukin-33 in human epidermal keratinocytes: a new mediator of atopic dermatitis and its possible signaling pathway. J Interferon Cytokine Res 36(9):552\u2013562. https:\/\/doi.org\/10.1089\/jir.2015.0159","journal-title":"J Interferon Cytokine Res"},{"issue":"5","key":"9196_CR61","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jaad.2014.01.867","volume":"70","author":"R Tamagawa-Mineoka","year":"2014","unstructured":"Tamagawa-Mineoka R, Okuzawa Y, Masuda K, Katoh N (2014) Increased serum levels of interleukin 33 in patients with atopic dermatitis. J Am Acad Dermatol 70(5):882\u2013888. https:\/\/doi.org\/10.1016\/j.jaad.2014.01.867","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"9196_CR62","doi-asserted-by":"publisher","first-page":"e70351","DOI":"10.1002\/iid3.70351","volume":"14","author":"AR Ghasemiyeh","year":"2026","unstructured":"Ghasemiyeh AR, Arani MH, Riazian F, Aghajani A, Azadchehr MJ, Motedayyen H (2026) Predicting role of interleukin-33 in determining the development and severity of atopic dermatitis. Immun Inflamm Dis 14(2):e70351. https:\/\/doi.org\/10.1002\/iid3.70351","journal-title":"Immun Inflamm Dis"},{"issue":"11","key":"9196_CR63","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/jdv.13679","volume":"30","author":"U Nygaard","year":"2016","unstructured":"Nygaard U, Hvid M, Johansen C, Buchner M, F\u00f6lster-Holst R, Deleuran M et al (2016) TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. J Eur Acad Dermatol Venereol 30(11):1930\u20131938. https:\/\/doi.org\/10.1111\/jdv.13679","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"9196_CR64","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","volume":"138","author":"M Akdis","year":"2016","unstructured":"Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R et al (2016) Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases. J Allergy Clin Immunol 138(4):984\u20131010. https:\/\/doi.org\/10.1016\/j.jaci.2016.06.033","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9196_CR65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaci.2020.12.628","volume":"148","author":"J Borowczyk","year":"2021","unstructured":"Borowczyk J, Shutova M, Brembilla NC, Boehncke W-H (2021) IL-25 (IL-17E) in epithelial immunology and pathophysiology. J Allergy Clin Immunol 148(1):40\u201352. https:\/\/doi.org\/10.1016\/j.jaci.2020.12.628","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"9196_CR66","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/biof.24","volume":"35","author":"JL Barlow","year":"2009","unstructured":"Barlow JL, McKenzie AN (2009) IL-25: a key requirement for the regulation of type-2 immunity. BioFactors 35(2):178\u2013182. https:\/\/doi.org\/10.1002\/biof.24","journal-title":"BioFactors"},{"issue":"2","key":"9196_CR67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1165\/rcmb.2005-0034OC","volume":"33","author":"CK Wong","year":"2005","unstructured":"Wong CK, Cheung PF, Ip WK, Lam CW (2005) Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 33(2):186\u2013194. https:\/\/doi.org\/10.1165\/rcmb.2005-0034OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"9196_CR68","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaci.2006.04.051","volume":"118","author":"T Tamachi","year":"2006","unstructured":"Tamachi T, Maezawa Y, Ikeda K, Kagami S, Hatano M, Seto Y et al (2006) IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J Allergy Clin Immunol 118(3):606\u2013614. https:\/\/doi.org\/10.1016\/j.jaci.2006.04.051","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"9196_CR69","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.4049\/jimmunol.181.6.4299","volume":"181","author":"EA Rickel","year":"2008","unstructured":"Rickel EA, Siegel LA, Yoon BR, Rottman JB, Kugler DG, Swart DA et al (2008) Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 181(6):4299\u20134310. https:\/\/doi.org\/10.4049\/jimmunol.181.6.4299","journal-title":"J Immunol"},{"issue":"12","key":"9196_CR70","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1038\/jid.2013.223","volume":"133","author":"BE Kim","year":"2013","unstructured":"Kim BE, Bin L, Ye YM, Ramamoorthy P, Leung DYM (2013) IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol 133(12):2678\u20132685. https:\/\/doi.org\/10.1038\/jid.2013.223","journal-title":"J Invest Dermatol"},{"issue":"1","key":"9196_CR71","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/jid.2010.277","volume":"131","author":"M Hvid","year":"2011","unstructured":"Hvid M, Vestergaard C, Kemp K, Christensen GB, Deleuran B, Deleuran M (2011) IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 131(1):150\u2013157. https:\/\/doi.org\/10.1038\/jid.2010.277","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9196_CR72","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","volume":"127","author":"M Su\u00e1rez-Fari\u00f1as","year":"2011","unstructured":"Su\u00e1rez-Fari\u00f1as M, Tintle SJ, Shemer A, Chiricozzi A, Nograles K, Cardinale I et al (2011) Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127(4):954\u2013964.e1-4.https:\/\/doi.org\/10.1016\/j.jaci.2010.12.1124","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"9196_CR73","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1084\/jem.20070406","volume":"204","author":"YH Wang","year":"2007","unstructured":"Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S et al (2007) IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 204(8):1837\u20131847. https:\/\/doi.org\/10.1084\/jem.20070406","journal-title":"J Exp Med"},{"issue":"7","key":"9196_CR74","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.4049\/jimmunol.1800696","volume":"202","author":"V Ramirez-Carrozzi","year":"2019","unstructured":"Ramirez-Carrozzi V, Ota N, Sambandam A, Wong K, Hackney J, Martinez-Martin N et al (2019) Cutting edge: IL-17B uses IL-17RA and IL-17RB to induce type 2 inflammation from human lymphocytes. J Immunol 202(7):1935\u20131941. https:\/\/doi.org\/10.4049\/jimmunol.1800696","journal-title":"J Immunol"},{"key":"9196_CR75","doi-asserted-by":"publisher","first-page":"1559372","DOI":"10.3389\/fmed.2025.1559372","volume":"12","author":"X Hong","year":"2025","unstructured":"Hong X, Wang X, Cheng Y, Song H, Xu C, Wang P (2025) Serum levels of interleukin-17, -18, -22, and \u2013\u200925 in patients with bullous pemphigoid before and after treatment. Front Med (Lausanne) 12:1559372. https:\/\/doi.org\/10.3389\/fmed.2025.1559372","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"9196_CR76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/1203475420982553","volume":"25","author":"K Ratnarajah","year":"2021","unstructured":"Ratnarajah K, Le M, Muntyanu A, Mathieu S, Nigen S, Litvinov IV et al (2021) Inhibition of IL-13: a new pathway for atopic dermatitis. J Cutan Med Surg 25(3):315\u2013328. https:\/\/doi.org\/10.1177\/1203475420982553","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"9196_CR77","doi-asserted-by":"publisher","first-page":"100131","DOI":"10.1016\/j.xjidi.2022.100131","volume":"2","author":"LA Beck","year":"2022","unstructured":"Beck LA, Cork MJ, Amagai M, De Benedetto A, Kabashima K, Hamilton JD et al (2022) Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov 2(5):100131. https:\/\/doi.org\/10.1016\/j.xjidi.2022.100131","journal-title":"JID Innov"},{"issue":"6","key":"9196_CR78","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.jaci.2020.02.026","volume":"145","author":"JM Leyva-Castillo","year":"2020","unstructured":"Leyva-Castillo JM, Galand C, Mashiko S, Bissonnette R, McGurk A, Ziegler SF et al (2020) ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation. J Allergy Clin Immunol 145(6):1606\u201314e4. https:\/\/doi.org\/10.1016\/j.jaci.2020.02.026","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"9196_CR79","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/mi.2009.134","volume":"3","author":"MR Comeau","year":"2010","unstructured":"Comeau MR, Ziegler SF (2010) The influence of TSLP on the allergic response. Mucosal Immunol 3(2):138\u2013147. https:\/\/doi.org\/10.1038\/mi.2009.134","journal-title":"Mucosal Immunol"},{"issue":"1","key":"9196_CR80","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41598-017-00670-2","volume":"7","author":"L Wallmeyer","year":"2017","unstructured":"Wallmeyer L, Dietert K, Sochorov\u00e1 M, Gruber AD, Kleuser B, V\u00e1vrov\u00e1 K et al (2017) TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents. Sci Rep 7(1):774. https:\/\/doi.org\/10.1038\/s41598-017-00670-2","journal-title":"Sci Rep"},{"issue":"4","key":"9196_CR81","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4168\/aair.2014.6.4.276","volume":"6","author":"H-J Lee","year":"2014","unstructured":"Lee H-J, Lee S-H (2014) Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol Res 6(4):276\u2013287. https:\/\/doi.org\/10.4168\/aair.2014.6.4.276","journal-title":"Allergy Asthma Immunol Res"},{"key":"9196_CR82","doi-asserted-by":"publisher","unstructured":"Chan BCL, Lam CWK, Tam L-S, Wong CK (2019) IL33: roles in allergic inflammation and therapeutic perspectives. Front Immunol 10:2019. https:\/\/doi.org\/10.3389\/fimmu.2019.00364","DOI":"10.3389\/fimmu.2019.00364"},{"issue":"1","key":"9196_CR83","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41598-018-21589-2","volume":"8","author":"IC Scott","year":"2018","unstructured":"Scott IC, Majithiya JB, Sanden C, Thornton P, Sanders PN, Moore T et al (2018) Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage. Sci Rep 8(1):3363. https:\/\/doi.org\/10.1038\/s41598-018-21589-2","journal-title":"Sci Rep"},{"issue":"22","key":"9196_CR84","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.1016\/j.cell.2025.08.017","volume":"188","author":"VS Cortez","year":"2025","unstructured":"Cortez VS, Viragova S, Koga S, Liu M, O\u2019Leary CE, Ricardo-Gonzalez RR et al (2025) IL-25-induced memory type 2 innate lymphoid cells enforce mucosal immunity. Cell 188(22):6220\u201335e22. https:\/\/doi.org\/10.1016\/j.cell.2025.08.017","journal-title":"Cell"},{"issue":"16","key":"9196_CR85","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.3390\/ijms241612725","volume":"24","author":"S Smolinska","year":"2023","unstructured":"Smolinska S, Antol\u00edn-Am\u00e9rigo D, Popescu FD, Jutel M (2023) Thymic stromal lymphopoietin (TSLP), its isoforms and the interplay with the epithelium in allergy and asthma. Int J Mol Sci 24(16):12725. https:\/\/doi.org\/10.3390\/ijms241612725","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9196_CR86","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/jid.2015.406","volume":"136","author":"GD Rak","year":"2016","unstructured":"Rak GD, Osborne LC, Siracusa MC, Kim BS, Wang K, Bayat A et al (2016) IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing. J Invest Dermatol 136(2):487\u2013496. https:\/\/doi.org\/10.1038\/jid.2015.406","journal-title":"J Invest Dermatol"},{"issue":"34","key":"9196_CR87","doi-asserted-by":"publisher","first-page":"13921","DOI":"10.1073\/pnas.1307321110","volume":"110","author":"Y Imai","year":"2013","unstructured":"Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yoshimoto T et al (2013) Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A 110(34):13921\u201313926. https:\/\/doi.org\/10.1073\/pnas.1307321110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"9196_CR88","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jid.2019.12.013","volume":"140","author":"J Borowczyk","year":"2020","unstructured":"Borowczyk J, Buerger C, Tadjrischi N, Drukala J, Wolnicki M, Wnuk D et al (2020) IL-17E (IL-25) and IL-17A differentially affect the functions of human keratinocytes. J Invest Dermatol 140(7):1379\u201389e2. https:\/\/doi.org\/10.1016\/j.jid.2019.12.013","journal-title":"J Invest Dermatol"},{"key":"9196_CR89","doi-asserted-by":"publisher","first-page":"111899","DOI":"10.1016\/j.intimp.2024.111899","volume":"131","author":"HF Lu","year":"2024","unstructured":"Lu HF, Zhou YC, Luo DD, Yang DH, Wang XJ, Cheng BH et al (2024) ILC2s: unraveling the innate immune orchestrators in allergic inflammation. Int Immunopharmacol 131:111899. https:\/\/doi.org\/10.1016\/j.intimp.2024.111899","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"9196_CR90","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.jaci.2020.01.042","volume":"145","author":"H He","year":"2020","unstructured":"He H, Suryawanshi H, Morozov P, Gay-Mimbrera J, Del Duca E, Kim HJ et al (2020) Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis. J Allergy Clin Immunol 145(6):1615\u20131628. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.042","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9196_CR91","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jaci.2010.08.041","volume":"126","author":"MK Oyoshi","year":"2010","unstructured":"Oyoshi MK, Larson RP, Ziegler SF, Geha RS (2010) Mechanical injury polarizes skin dendritic cells to elicit a T\u2009<\u2009sub>H\u20092 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol 126(5):976\u201384e5. https:\/\/doi.org\/10.1016\/j.jaci.2010.08.041","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"9196_CR92","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","volume":"210","author":"M Salimi","year":"2013","unstructured":"Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X et al (2013) A role for IL-25 and IL-33\u2013driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210(13):2939\u20132950. https:\/\/doi.org\/10.1084\/jem.20130351","journal-title":"J Exp Med"},{"issue":"4","key":"9196_CR93","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/ni1048","volume":"5","author":"N Watanabe","year":"2004","unstructured":"Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R et al (2004) Human thymic stromal lymphopoietin promotes dendritic cell\u2013mediated CD4\u2009+\u2009T cell homeostatic expansion. Nat Immunol 5(4):426\u2013434. https:\/\/doi.org\/10.1038\/ni1048","journal-title":"Nat Immunol"},{"issue":"5","key":"9196_CR94","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479\u2013490. https:\/\/doi.org\/10.1016\/j.immuni.2005.09.015","journal-title":"Immunity"},{"issue":"8","key":"9196_CR95","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","volume":"193","author":"BM Matta","year":"2014","unstructured":"Matta BM, Lott JM, Mathews LR, Liu Q, Rosborough BR, Blazar BR et al (2014) IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2\u2009+\u2009regulatory T cells. J Immunol 193(8):4010\u20134020. https:\/\/doi.org\/10.4049\/jimmunol.1400481","journal-title":"J Immunol"},{"issue":"10","key":"9196_CR96","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1182\/bloodadvances.2016002352","volume":"1","author":"A Camelo","year":"2017","unstructured":"Camelo A, Rosignoli G, Ohne Y, Stewart RA, Overed-Sayer C, Sleeman MA et al (2017) IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells. Blood Adv 1(10):577\u2013589. https:\/\/doi.org\/10.1182\/bloodadvances.2016002352","journal-title":"Blood Adv"},{"issue":"170","key":"9196_CR97","doi-asserted-by":"publisher","first-page":"170ra16","DOI":"10.1126\/scitranslmed.3005374","volume":"5","author":"BS Kim","year":"2013","unstructured":"Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF et al (2013) TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 5(170):170ra16. https:\/\/doi.org\/10.1126\/scitranslmed.3005374","journal-title":"Sci Transl Med"},{"issue":"7","key":"9196_CR98","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1053\/j.gastro.2009.02.049","volume":"136","author":"R Caruso","year":"2009","unstructured":"Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC et al (2009) Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 136(7):2270\u20132279. https:\/\/doi.org\/10.1053\/j.gastro.2009.02.049","journal-title":"Gastroenterology"},{"issue":"1","key":"9196_CR99","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1084\/jem.20061738","volume":"204","author":"MA Kleinschek","year":"2007","unstructured":"Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM et al (2007) IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204(1):161\u2013170. https:\/\/doi.org\/10.1084\/jem.20061738","journal-title":"J Exp Med"},{"key":"9196_CR100","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejphar.2015.04.047","volume":"778","author":"R Saluja","year":"2016","unstructured":"Saluja R, Zoltowska A, Ketelaar ME, Nilsson G (2016) IL-33 and thymic stromal lymphopoietin in mast cell functions. Eur J Pharmacol 778:68\u201376. https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.047","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"9196_CR101","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.4049\/jimmunol.1601825","volume":"198","author":"KD Chhiba","year":"2017","unstructured":"Chhiba KD, Hsu CL, Berdnikovs S, Bryce PJ (2017) Transcriptional heterogeneity of mast cells and basophils upon activation. J Immunol 198(12):4868\u20134878. https:\/\/doi.org\/10.4049\/jimmunol.1601825","journal-title":"J Immunol"},{"issue":"3","key":"9196_CR102","first-page":"321","volume":"22","author":"SL Friend","year":"1994","unstructured":"Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, Farr A (1994) A thymic stromal cell line supports in vitro development of surface IgM\u2009+\u2009B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 22(3):321\u2013328","journal-title":"Exp Hematol"},{"issue":"6","key":"9196_CR103","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.immuni.2006.03.019","volume":"24","author":"YH Wang","year":"2006","unstructured":"Wang YH, Ito T, Wang YH, Homey B, Watanabe N, Martin R et al (2006) Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 24(6):827\u2013838. https:\/\/doi.org\/10.1016\/j.immuni.2006.03.019","journal-title":"Immunity"},{"issue":"12","key":"9196_CR104","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1038\/jid.2015.318","volume":"135","author":"K Tatsuno","year":"2015","unstructured":"Tatsuno K, Fujiyama T, Yamaguchi H, Waki M, Tokura Y (2015) TSLP directly interacts with skin-homing Th2 cells highly expressing its receptor to enhance IL-4 production in atopic dermatitis. J Invest Dermatol 135(12):3017\u20133024. https:\/\/doi.org\/10.1038\/jid.2015.318","journal-title":"J Invest Dermatol"},{"key":"9196_CR105","doi-asserted-by":"publisher","unstructured":"Bangert C, Rindler K, Krausgruber T, Alkon N, Thaler FM, Kurz H et al (2021) Persistence of mature dendritic cells, T(H)2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4R\u03b1 blockade. Sci Immunol 6(55). https:\/\/doi.org\/10.1126\/sciimmunol.abe2749","DOI":"10.1126\/sciimmunol.abe2749"},{"issue":"3","key":"9196_CR106","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2332\/allergolint.13-OA-0672","volume":"63","author":"N Murakami-Satsutani","year":"2014","unstructured":"Murakami-Satsutani N, Ito T, Nakanishi T, Inagaki N, Tanaka A, Vien PTX et al (2014) IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligand. Allergol Int 63(3):443\u2013455. https:\/\/doi.org\/10.2332\/allergolint.13-OA-0672","journal-title":"Allergol Int"},{"issue":"7677","key":"9196_CR107","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature24271","volume":"550","author":"S Naik","year":"2017","unstructured":"Naik S, Larsen SB, Gomez NC, Alaverdyan K, Sendoel A, Yuan S et al (2017) Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature 550(7677):475\u2013480. https:\/\/doi.org\/10.1038\/nature24271","journal-title":"Nature"},{"issue":"1","key":"9196_CR108","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40364-023-00474-9","volume":"11","author":"Q Yuan","year":"2023","unstructured":"Yuan Q, Peng N, Xiao F, Shi X, Zhu B, Rui K et al (2023) New insights into the function of Interleukin-25 in disease pathogenesis. Biomark Res 11(1):36. https:\/\/doi.org\/10.1186\/s40364-023-00474-9","journal-title":"Biomark Res"},{"issue":"11","key":"9196_CR109","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.jid.2016.05.127","volume":"136","author":"T Nakatsuji","year":"2016","unstructured":"Nakatsuji T, Chen TH, Two AM, Chun KA, Narala S, Geha RS et al (2016) Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression. J Invest Dermatol 136(11):2192\u20132200. https:\/\/doi.org\/10.1016\/j.jid.2016.05.127","journal-title":"J Invest Dermatol"},{"issue":"5","key":"9196_CR110","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jaci.2010.09.002","volume":"126","author":"AT Vu","year":"2010","unstructured":"Vu AT, Baba T, Chen X, Le TA, Kinoshita H, Xie Y et al (2010) Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway. J Allergy Clin Immunol 126(5):985\u2013993. https:\/\/doi.org\/10.1016\/j.jaci.2010.09.002. 93.e1-3","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"9196_CR111","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3390\/toxins14070464","volume":"14","author":"H Chen","year":"2022","unstructured":"Chen H, Zhang J, He Y, Lv Z, Liang Z, Chen J et al (2022) Exploring the role of staphylococcus aureus in inflammatory diseases. Toxins 14(7):464. https:\/\/doi.org\/10.3390\/toxins14070464","journal-title":"Toxins"},{"issue":"5","key":"9196_CR112","doi-asserted-by":"publisher","first-page":"e0168423","DOI":"10.1128\/spectrum.01684-23","volume":"11","author":"MC Moran","year":"2023","unstructured":"Moran MC, Brewer MG, Schlievert PM, Beck LA (2023) S. aureus virulence factors decrease epithelial barrier function and increase susceptibility to viral infection. Microbiol Spectr 11(5):e0168423. https:\/\/doi.org\/10.1128\/spectrum.01684-23","journal-title":"Microbiol Spectr"},{"issue":"4","key":"9196_CR113","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jaci.2015.07.052","volume":"137","author":"M Tauber","year":"2016","unstructured":"Tauber M, Balica S, Hsu C-Y, Jean-Decoster C, Lauze C, Redoules D et al (2016) Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis. J Allergy Clin Immunol 137(4):1272\u20134e3. https:\/\/doi.org\/10.1016\/j.jaci.2015.07.052","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"9196_CR114","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.jid.2016.07.027","volume":"136","author":"H Lee","year":"2016","unstructured":"Lee H, Ryu WI, Kim HJ, Bae HC, Ryu HJ, Shin JJ et al (2016) TSLP down-regulates S100A7 and \u03b2-defensin 2 via the JAK2\/STAT3-dependent mechanism. J Invest Dermatol 136(12):2427\u20132435. https:\/\/doi.org\/10.1016\/j.jid.2016.07.027","journal-title":"J Invest Dermatol"},{"issue":"3","key":"9196_CR115","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/1346-8138.17975","volume":"53","author":"G Peng","year":"2026","unstructured":"Peng G, Abudouwanli A, Sun Q, Tan Y, Zhao W, Yang M et al (2026) Role of antimicrobial peptides in the pathogenesis of atopic dermatitis. J Dermatol 53(3):372\u2013379. https:\/\/doi.org\/10.1111\/1346-8138.17975","journal-title":"J Dermatol"},{"issue":"4","key":"9196_CR116","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jid.2019.09.004","volume":"140","author":"AM Brauweiler","year":"2020","unstructured":"Brauweiler AM, Goleva E, Leung DYM (2020) Staphylococcus aureus lipoteichoic acid initiates a TSLP-basophil-IL4 axis in the skin. J Invest Dermatol 140(4):915. https:\/\/doi.org\/10.1016\/j.jid.2019.09.004. 7.e2","journal-title":"J Invest Dermatol"},{"issue":"3","key":"9196_CR117","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ajpath.2012.11.039","volume":"182","author":"CS Moniaga","year":"2013","unstructured":"Moniaga CS, Jeong SK, Egawa G, Nakajima S, Hara-Chikuma M, Jeon JE et al (2013) Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice. Am J Pathol 182(3):841\u2013851. https:\/\/doi.org\/10.1016\/j.ajpath.2012.11.039","journal-title":"Am J Pathol"},{"issue":"2","key":"9196_CR118","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.chom.2023.12.006","volume":"32","author":"J Cha","year":"2024","unstructured":"Cha J, Kim TG, Bhae E, Gwak HJ, Ju Y, Choe YH et al (2024) Skin microbe-dependent TSLP-ILC2 priming axis in early life is co-opted in allergic inflammation. Cell Host Microbe 32(2):244\u201360e11. https:\/\/doi.org\/10.1016\/j.chom.2023.12.006","journal-title":"Cell Host Microbe"},{"issue":"12","key":"9196_CR119","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.jid.2017.07.834","volume":"137","author":"P Meylan","year":"2017","unstructured":"Meylan P, Lang C, Mermoud S, Johannsen A, Norrenberg S, Hohl D et al (2017) Skin colonization by Staphylococcus aureus precedes the clinical diagnosis of atopic dermatitis in infancy. J Invest Dermatol 137(12):2497\u20132504. https:\/\/doi.org\/10.1016\/j.jid.2017.07.834","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9196_CR120","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jaci.2020.09.023","volume":"147","author":"A Al Kindi","year":"2021","unstructured":"Al Kindi A, Williams H, Matsuda K, Alkahtani AM, Saville C, Bennett H et al (2021) Staphylococcus aureus second immunoglobulin-binding protein drives atopic dermatitis via IL-33. J Allergy Clin Immunol 147(4):1354\u201368e3. https:\/\/doi.org\/10.1016\/j.jaci.2020.09.023","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"9196_CR121","doi-asserted-by":"publisher","first-page":"e166821","DOI":"10.1172\/jci.insight.166821","volume":"9","author":"CH Luo","year":"2024","unstructured":"Luo CH, Lai AC, Tsai CC, Chen WY, Chang YS, Chung EJ et al (2024) Staphylococcus aureus exacerbates dermal IL-33\/ILC2 axis activation through evoking RIPK3\/MLKL-mediated necroptosis of dry skin. JCI Insight 9(6):e166821. https:\/\/doi.org\/10.1172\/jci.insight.166821","journal-title":"JCI Insight"},{"key":"9196_CR122","doi-asserted-by":"publisher","first-page":"1114699","DOI":"10.3389\/fimmu.2023.1114699","volume":"14","author":"CH Luo","year":"2023","unstructured":"Luo CH, Lai AC, Chang YJ (2023) Butyrate inhibits staphylococcus aureus-aggravated dermal IL-33 expression and skin inflammation through histone deacetylase inhibition. Front Immunol 14:1114699. https:\/\/doi.org\/10.3389\/fimmu.2023.1114699","journal-title":"Front Immunol"},{"key":"9196_CR123","doi-asserted-by":"publisher","first-page":"106256","DOI":"10.1016\/j.intimp.2020.106256","volume":"81","author":"X Wang","year":"2020","unstructured":"Wang X, Li X, Chen L, Yuan B, Liu T, Dong Q et al (2020) Interleukin-33 facilitates cutaneous defense against Staphylococcus aureus by promoting the development of neutrophil extracellular trap. Int Immunopharmacol 81:106256. https:\/\/doi.org\/10.1016\/j.intimp.2020.106256","journal-title":"Int Immunopharmacol"},{"key":"9196_CR124","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fphar.2018.00533","volume":"9","author":"M Li","year":"2018","unstructured":"Li M, van Esch BCAM, Henricks PAJ, Folkerts G, Garssen J (2018) The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor \u03b1-stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs. Front Pharmacol 9:533. https:\/\/doi.org\/10.3389\/fphar.2018.00533","journal-title":"Front Pharmacol"},{"issue":"5","key":"9196_CR125","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/ijms22052447","volume":"22","author":"M Li","year":"2021","unstructured":"Li M, van Esch B, Henricks PAJ, Garssen J, Folkerts G (2021) IL-33 is involved in the anti-inflammatory effects of butyrate and propionate on TNF\u03b1-activated endothelial cells. Int J Mol Sci 22(5):2447. https:\/\/doi.org\/10.3390\/ijms22052447","journal-title":"Int J Mol Sci"},{"key":"9196_CR126","doi-asserted-by":"publisher","first-page":"1083432","DOI":"10.3389\/fmicb.2022.1083432","volume":"13","author":"X Xiao","year":"2022","unstructured":"Xiao X, Hu X, Yao J, Cao W, Zou Z, Wang L et al (2022) The role of short-chain fatty acids in inflammatory skin diseases. Front Microbiol 13:1083432. https:\/\/doi.org\/10.3389\/fmicb.2022.1083432","journal-title":"Front Microbiol"},{"issue":"6","key":"9196_CR127","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/s1074-7613(01)00243-6","volume":"15","author":"MM Fort","year":"2001","unstructured":"Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S et al (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15(6):985\u2013995. https:\/\/doi.org\/10.1016\/s1074-7613(01)00243-6","journal-title":"Immunity"},{"issue":"3","key":"9196_CR128","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12016-015-8488-5","volume":"51","author":"NK Mollanazar","year":"2016","unstructured":"Mollanazar NK, Smith PK, Yosipovitch G (2016) Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol 51(3):263\u2013292. https:\/\/doi.org\/10.1007\/s12016-015-8488-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"9196_CR129","doi-asserted-by":"publisher","unstructured":"Schwendinger-Schreck J, Wilson SR, Bautista DM (2015) Interactions between keratinocytes and somatosensory neurons in itch. Handb Exp Pharmacol 226. https:\/\/doi.org\/10.1007\/978-3-662-44605-8_10. :177\u2009\u2013\u200990","DOI":"10.1007\/978-3-662-44605-8_10"},{"issue":"3","key":"9196_CR130","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/vaccines9030303","volume":"9","author":"S Garcovich","year":"2021","unstructured":"Garcovich S, Maurelli M, Gisondi P, Peris K, Yosipovitch G, Girolomoni G (2021) Pruritus as a distinctive feature of type 2 inflammation. Vaccines (Basel) 9(3):303. https:\/\/doi.org\/10.3390\/vaccines9030303","journal-title":"Vaccines (Basel)"},{"key":"9196_CR131","doi-asserted-by":"publisher","first-page":"772941","DOI":"10.3389\/fimmu.2021.772941","volume":"12","author":"WJ Lee","year":"2021","unstructured":"Lee WJ, Shim WS (2021) Cutaneous neuroimmune interactions of TSLP and TRPV4 play pivotal roles in dry skin-induced pruritus. Front Immunol 12:772941. https:\/\/doi.org\/10.3389\/fimmu.2021.772941","journal-title":"Front Immunol"},{"issue":"12","key":"9196_CR132","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3390\/ph16121707","volume":"16","author":"MG Tsagareli","year":"2023","unstructured":"Tsagareli MG, Follansbee T, Iodi Carstens M, Carstens E (2023) Targeting transient receptor potential (TRP) channels, Mas-related G-protein-coupled receptors (Mrgprs), and protease-activated receptors (PARs) to relieve itch. Pharmaceuticals (Basel) 16(12):1707. https:\/\/doi.org\/10.3390\/ph16121707","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"9196_CR133","doi-asserted-by":"publisher","first-page":"26894","DOI":"10.1038\/srep26894","volume":"6","author":"P Kanju","year":"2016","unstructured":"Kanju P, Chen Y, Lee W, Yeo M, Lee SH, Romac J et al (2016) Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain. Sci Rep 6(1):26894. https:\/\/doi.org\/10.1038\/srep26894","journal-title":"Sci Rep"},{"issue":"1","key":"9196_CR134","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/bjd.17940","volume":"182","author":"D Redhu","year":"2020","unstructured":"Redhu D, Franke K, Kumari V, Francuzik W, Babina M, Worm M (2020) Thymic stromal lymphopoietin production induced by skin irritation results from concomitant activation of protease-activated receptor 2 and interleukin 1 pathways. Br J Dermatol 182(1):119\u2013129. https:\/\/doi.org\/10.1111\/bjd.17940","journal-title":"Br J Dermatol"},{"issue":"1","key":"9196_CR135","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/cells10010102","volume":"10","author":"M Babina","year":"2021","unstructured":"Babina M, Wang Z, Franke K, Zuberbier T (2021) Thymic stromal lymphopoietin promotes MRGPRX2-triggered degranulation of skin mast cells in a STAT5-dependent manner with further support from JNK. Cells 10(1):102. https:\/\/doi.org\/10.3390\/cells10010102","journal-title":"Cells"},{"issue":"4","key":"9196_CR136","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.bjp.0704303","volume":"134","author":"SJ Compton","year":"2001","unstructured":"Compton SJ, Renaux B, Wijesuriya SJ, Hollenberg MD (2001) Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase. Br J Pharmacol 134(4):705\u2013718. https:\/\/doi.org\/10.1038\/sj.bjp.0704303","journal-title":"Br J Pharmacol"},{"issue":"7","key":"9196_CR137","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/eji.201041195","volume":"41","author":"M Kitajima","year":"2011","unstructured":"Kitajima M, Lee HC, Nakayama T, Ziegler SF (2011) TSLP enhances the function of helper type 2 cells. Eur J Immunol 41(7):1862\u20131871. https:\/\/doi.org\/10.1002\/eji.201041195","journal-title":"Eur J Immunol"},{"issue":"5","key":"9196_CR138","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.anai.2010.09.017","volume":"105","author":"KD Alysandratos","year":"2010","unstructured":"Alysandratos KD, Angelidou A, Vasiadi M, Zhang B, Kalogeromitros D, Katsarou-Katsari A et al (2010) Increased affected skin gene expression and serum levels of thymic stromal lymphopoietin in atopic dermatitis. Ann Allergy Asthma Immunol 105(5):403\u2013404. https:\/\/doi.org\/10.1016\/j.anai.2010.09.017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"47","key":"9196_CR139","doi-asserted-by":"publisher","first-page":"E7572","DOI":"10.1073\/pnas.1606608113","volume":"113","author":"B Liu","year":"2016","unstructured":"Liu B, Tai Y, Achanta S, Kaelberer MM, Caceres AI, Shao X et al (2016) IL-33\/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy. Proc Natl Acad Sci U S A 113(47):E7572\u2013e9. https:\/\/doi.org\/10.1073\/pnas.1606608113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9196_CR140","doi-asserted-by":"publisher","unstructured":"Franke K, Li Z, Bal G, Zuberbier T, Babina M (2023) Synergism between IL-33 and MRGPRX2\/Fc\u03b5RI is primarily due to the complementation of signaling modules, and only modestly supplemented by prolonged activation of selected kinases. Cells 12(23). https:\/\/doi.org\/10.3390\/cells12232700","DOI":"10.3390\/cells12232700"},{"issue":"7","key":"9196_CR141","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.3390\/ijms22073580","volume":"22","author":"K Franke","year":"2021","unstructured":"Franke K, Wang Z, Zuberbier T, Babina M (2021) Cytokines stimulated by IL-33 in human skin mast cells: involvement of NF-\u03baB and p38 at distinct levels and potent co-operation with Fc\u03b5RI and MRGPRX2. Int J Mol Sci 22(7):3580. https:\/\/doi.org\/10.3390\/ijms22073580","journal-title":"Int J Mol Sci"},{"issue":"4","key":"9196_CR142","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/cells8040341","volume":"8","author":"Z Wang","year":"2019","unstructured":"Wang Z, Guhl S, Franke K, Artuc M, Zuberbier T, Babina M (2019) IL-33 and MRGPRX2-triggered activation of human skin mast cells\u2014elimination of receptor expression on chronic exposure, but reinforced degranulation on acute priming. Cells 8(4):341. https:\/\/doi.org\/10.3390\/cells8040341","journal-title":"Cells"},{"issue":"3","key":"9196_CR143","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jaci.2023.08.038","volume":"153","author":"AM Trier","year":"2024","unstructured":"Trier AM, Ver Heul AM, Fredman A, Le V, Wang Z, Auyeung K et al (2024) IL-33 potentiates histaminergic itch. J Allergy Clin Immunol 153(3):852\u20139e3. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.038","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"9196_CR144","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/s41590-024-01982-y","volume":"25","author":"JM Inclan-Rico","year":"2024","unstructured":"Inclan-Rico JM, Napuri CM, Lin C, Hung LY, Ferguson AA, Liu X et al (2024) MrgprA3 neurons drive cutaneous immunity against helminths through selective control of myeloid-derived IL-33. Nat Immunol 25(11):2068\u20132084. https:\/\/doi.org\/10.1038\/s41590-024-01982-y","journal-title":"Nat Immunol"},{"issue":"2","key":"9196_CR145","doi-asserted-by":"publisher","first-page":"AB364","DOI":"10.1016\/j.jaci.2012.01.004","volume":"129","author":"B Kim","year":"2012","unstructured":"Kim B, Bin L, Leung DY (2012) IL-25 down-regulates epidermal barrier proteins and enhances viral replication. J Allergy Clin Immunol 129(2):AB364. https:\/\/doi.org\/10.1016\/j.jaci.2012.01.004","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"9196_CR146","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/all.12633","volume":"70","author":"MK Aktar","year":"2015","unstructured":"Aktar MK, Kido-Nakahara M, Furue M, Nakahara T (2015) Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis. Allergy 70(7):846\u2013854. https:\/\/doi.org\/10.1111\/all.12633","journal-title":"Allergy"},{"issue":"3","key":"9196_CR147","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/all.70149","volume":"81","author":"R Leo","year":"2026","unstructured":"Leo R, Jochebeth A, Abdulrahman N, Agha MV, Joy FE, AlHammadi A et al (2026) The neurogenic inflammation mediator endothelin-1 causes human skin barrier disruption in atopic dermatitis via an ETAR\/TRPA1-axis. Allergy 81(3):818\u2013829. https:\/\/doi.org\/10.1111\/all.70149","journal-title":"Allergy"},{"issue":"2","key":"9196_CR148","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/sj.bjp.0707216","volume":"151","author":"DS McQueen","year":"2007","unstructured":"McQueen DS, Noble MA, Bond SM (2007) Endothelin-1 activates ETA receptors to cause reflex scratching in BALB\/c mice. Br J Pharmacol 151(2):278\u2013284. https:\/\/doi.org\/10.1038\/sj.bjp.0707216","journal-title":"Br J Pharmacol"},{"key":"9196_CR149","doi-asserted-by":"publisher","first-page":"106528","DOI":"10.1016\/j.ejim.2025.106528","volume":"143","author":"R Poto","year":"2026","unstructured":"Poto R, Manganello G, di Salvatore A, Capitelli L, Lagnese G, Messuri C et al (2026) Effectiveness of tezepelumab in severe asthma: a multicenter real-world study. Eur J Intern Med 143:106528. https:\/\/doi.org\/10.1016\/j.ejim.2025.106528","journal-title":"Eur J Intern Med"},{"issue":"4","key":"9196_CR150","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2018.11.059","volume":"80","author":"EL Simpson","year":"2019","unstructured":"Simpson EL, Parnes JR, She D, Crouch S, Rees W, Mo M et al (2019) Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial. J Am Acad Dermatol 80(4):1013\u20131021. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.059","journal-title":"J Am Acad Dermatol"},{"key":"9196_CR151","unstructured":"(2015) A phase 2a, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of MEDI9929 in adult subjects with moderate-to-severe atopic dermatitis [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02525094"},{"issue":"Abstracts","key":"9196_CR152","doi-asserted-by":"publisher","first-page":"A1393","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A1393","volume":"211","author":"K Komori","year":"2025","unstructured":"Komori K, Lore M, Postlethwaite H, Manga V, Wittmer LL, Ortega H (2025) In-vitro characterization of solrikitug, a differentiated anti-TSLP antibody, provides distinct epitope binding profile and superior potency compared to tezepelumab. Am J Respir Crit Care Med 211(Abstracts):A1393\u2013A. https:\/\/doi.org\/10.1164\/ajrccm.2025.211.Abstracts.A1393","journal-title":"Am J Respir Crit Care Med"},{"key":"9196_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.6115","author":"C Han","year":"2024","unstructured":"Han C, Fung I, Zhang D, Jin Y, Chen P, Tam S et al (2024) Phase 1 safety and pharmacokinetics study of TAVO101, an anti-human thymic stromal lymphopoietin antibody for the treatment of allergic inflammatory conditions. J Clin Pharmacol. https:\/\/doi.org\/10.1002\/jcph.6115","journal-title":"J Clin Pharmacol"},{"issue":"22","key":"9196_CR154","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/cells14221747","volume":"14","author":"M Yu","year":"2025","unstructured":"Yu M, Chen P, Jin Y, Huang S, Jiang H, Zhou F et al (2025) A bispecific antibody blocking both TSLP and IL-4R\u03b1 for the treatment of allergic inflammatory diseases. Cells 14(22):1747. https:\/\/doi.org\/10.3390\/cells14221747","journal-title":"Cells"},{"key":"9196_CR155","unstructured":"(2018) A randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study investigating the efficacy, safety, and pharmacokinetic profile of ANB020 administered to adult subjects with moderate-to-severe atopic dermatitis [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03533751"},{"key":"9196_CR156","unstructured":"(2018) A phase II, randomized, double-blind, placebo-controlled multicenter study to assess the efficacy and safety of MSTT1041A in patients with moderate to severe atopic dermatitis [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03747575"},{"key":"9196_CR157","unstructured":"(2019) A phase 2 randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of MEDI3506 in adult subjects with moderate-to-severe atopic dermatitis [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04212169"},{"issue":"8","key":"9196_CR158","doi-asserted-by":"publisher","first-page":"e13874","DOI":"10.1111\/cts.13874","volume":"17","author":"MP Kosloski","year":"2024","unstructured":"Kosloski MP, Guttman-Yassky E, Cork MJ, Worm M, Nahm DH, Zhu X et al (2024) Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials. Clin Transl Sci 17(8):e13874. https:\/\/doi.org\/10.1111\/cts.13874","journal-title":"Clin Transl Sci"},{"issue":"4","key":"9196_CR159","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/abt\/tbac022","volume":"5","author":"R Bone","year":"2022","unstructured":"Bone R, Fennell BJ, Tam A, Sheldon R, Nocka K, Varghese S et al (2022) Discovery and multi-parametric optimization of a high-affinity antibody against interleukin-25 with neutralizing activity in a mouse model of skin inflammation. Antib Ther 5(4):258\u2013267. https:\/\/doi.org\/10.1093\/abt\/tbac022","journal-title":"Antib Ther"},{"issue":"Supplement2","key":"9196_CR160","doi-asserted-by":"publisher","first-page":"ii17","DOI":"10.1093\/bjd\/ljad498.020","volume":"190","author":"TCW Hui","year":"2024","unstructured":"Hui TCW, Lam LH, Li W, Chow KC, Leung SO (2024) 513 - Blockage of IL-25 pathway as a potential target therapy for atopic dermatitis. Br J Dermatol 190(Supplement2):ii17. https:\/\/doi.org\/10.1093\/bjd\/ljad498.020","journal-title":"Br J Dermatol"},{"key":"9196_CR161","unstructured":"(2008) A randomized, double-blind, placebo-controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AMG 157 in healthy subjects and subjects with moderate to severe atopic dermatitis [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00757042"},{"key":"9196_CR162","unstructured":"(2012) A phase Ib randomized, double-blinded, placebo-controlled multiple rising dose clinical trial to evaluate the safety, efficacy, pharmacokinetics, pharmacodynamics, and immunogenicity of intravenous MK-8226 in patients with moderate to severe atopic dermatitis [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01732510"},{"key":"9196_CR163","unstructured":"(2022) A phase 1, first-in-human, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SM17 when administered intravenously as a single ascending dose in healthy subjects (part A) and as multiple ascending doses in healthy subjects (part B) [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05332834"},{"key":"9196_CR164","unstructured":"(2026) A phase 2, randomized, double-blind, placebo-controlled, dose-finding clinical study to evaluate the efficacy and safety of SM17 monoclonal antibody injection (subcutaneous injection) in participants with moderate to severe atopic dermatitis [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07445919"},{"key":"9196_CR165","unstructured":"(2023) A randomized, double-blind, placebo-controlled, multiple ascending dose phase Ib clinical study to evaluate the safety, tolerability, and pharmacokinetics of XKH001 injection in healthy subjects [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05991661"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09196-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-026-09196-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09196-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:23:34Z","timestamp":1787754214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-026-09196-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9196"],"URL":"https:\/\/doi.org\/10.1007\/s12016-026-09196-w","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"69"}}